Posted by Joe Dangor (@joedangor) · Aug 19, 2014
Mayo Clinic Investigator to Lead Alliance Research Base for New National, Community-based Cancer Research Initiative
ROCHESTER, Minn. — The National Cancer Institute (NCI) has awarded Jan Buckner, M.D., a five-year, $47.5 million grant to lead the NCI’s National Community Oncology Research Program (NCORP) research base for the Alliance for Clinical Trials in Oncology. Dr. Buckner is deputy director for cancer practice at the Mayo Clinic Cancer Center in Rochester, where the Alliance research base will be located.
NCORP is a national network of cancer investigators, cancer care providers, academic institutions and other organizations that provide care to diverse populations in community-based health care practices across the United States. NCORP will design and conduct trials to improve cancer prevention, cancer control, screening and post-treatment management.
The Alliance research base at Mayo Clinic Cancer Center in Minnesota will be one of seven research bases across the country that will design and conduct multicenter cancer clinical trials and cancer care delivery research. NCORP hubs will also provide overall administration, data management, scientific leadership and regulatory compliance for the NCORP program.
NCORP includes 34 community sites that will accrue participants to clinical trials conducted by NCORP research bases, NCI National Clinical Trials Network (NCTN) treatment and imaging trials, quality-of-life studies, and cancer care delivery research involving patients, practitioners, and health care organizations.
NCORP also includes 12 minority/underserved community sites that will accrue participants in the same way as the community sites but have a patient population comprising at least 30 percent racial and ethnic minorities or rural residents.
“We are honored to have been selected as an NCORP research base,” says Dr. Buckner. “We share NCORP’s commitment to community-based research and increasing access to NCI research for minority, rural and other underserved patient populations.”
The Alliance for Clinical Trials in Oncology is part of a national clinical trials network sponsored by NCI. The Alliance comprises nearly 10,000 cancer specialists at hospitals, medical centers and community clinics across the United States and Canada. Through collaboration with the NCI National Clinical Trials Network (NCTN), the Alliance develops and conducts clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as research methods to alleviate side effects of cancer and cancer treatments.
About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 1-855-776-0015 (toll-free).
About Mayo Clinic
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150 years.mayoclinic.org, http://www.mayoclinic.org/ and newsnetwork.mayoclinic.org.
Page loaded in 0.763 seconds